Getinge AB., Azbil Corporation., and Cytiva Dominated the Global Pharmaceutical Isolators Market in 2021

The Global Pharmaceutical Isolators Market is expected to grow with a CAGR of 14.3% in the forecast period of 2022 to 2029. The years considered for the study are as mentioned below.

Access full Report @  https://www.databridgemarketresearch.com/reports/global-pharmaceutical-isolator-market

The global pharmaceutical isolators market is a highly consolidated market, which includes specific number of key players. It has witnessed increased strategic developments owing to favorable market scenarios.

The major players dealing in the market are introducing a wide range of healthcare information technology (IT) services and software and adopting strategic initiatives such as acquisition and agreement into the market. This helped companies to maximize sales with enhanced services portfolio.

Getinge AB is the market leader in the market. The other players in this market are SKAN AG, Hosokawa micron ltd, Gelman Singapore, Germfree Laboratories, Inc., M. Braun Inertgas-Systeme Gmbh, Nuaire, Iteco S.R.L., Comecer S.P.A., Hecht Technologie Gmbh, Steriline S.R.L., Envair Limited, Tema Sinergie S.P.A, Schematic Engineering Industries, Chiyoda Corporation, Chamunda Pharma Machinery Pvt. Ltd, Bioquell (Ecolab Solution), Jacomex, Fedegari Autoclavi S.p.A., LAF Technologies, ISO Tech Design, Esco Pharma among others.

Getinge AB

Getinge AB is headquartered in Västergötland, Sweden and was founded in 1904. The company is focused on providing isolators, which improve people’s quality of life and save lives. The company offers various product categories including intensive care, cardiovascular procedures, operating room, sterile reprocessing, digital health, and pharmaceutical production, among which pharmaceutical production is the market focused category.

The company has around 10,700 employees. It operates in various subsidiaries, which are. Getinge Life Science France SAS (France), Getinge Medical India Pvt Ltd (India), Getinge Group Middle East FZ-LLC (UAE) among others.

For instance,

  • In July, GetingeAB, announced the voluntary expansion of its global pharmaceutical medical devices to HLS Set Advanced products due to a potential breach of sterile packaging. Getinge has informed the relevant authorities about this field operation in accordance with current regulations. So far, there are no known side effects related to illnesses or injuries related to this issue. This has helped the company to expand their product portfolio.

The company has wide presence across North America, Europe, Asia-Pacific and Middle East and Africa.

Cytiva (A subsidiary of Danaher Corporation)

Cytiva, is headquartered in Pennyslavania,, U.S. and was founded in 1978. The company focuses on bioprocessing products and services to the biopharmaceutical industry for the development and manufacture of therapeutics and vaccines. The company has aseptic filling, bioprocess filtration, cell culture and fermentation processes, cell therapy technologies, chromatography products, laboratory supplies and accessories, liquid preparation and management, molecular biology and biochemistry, protein analysis equipment and supplies, whatman filters, membranes, analytical as product categories. Aseptic filing is the market focused category.

The business segments are Life Sciences, Environmental & Applied Solutions, and Diagnostics among which Environmental & Applied Solutions is the market focused segment.

 For instance,

  • In February 2021, Cytiva, acquired Vanrx Pharmasystems, an aseptic filling innovator from Canada. The acquisition resulted in strengthening the product portfolio in Europe market.

The company has wide presence in North America, Europe, Asia-Pacific, Middle East and Africa. The subsidiaries are Intermountain Life Sciences, LLC (U.S.), Vanrx Pharmasystems Inc. (Canada), CEVEC Pharmaceuticals GmbH (Germany), and GoSilico GmbH (Germany) among others.

Pharmaceutical Isolators Market

Azbil Corporation.

Azbil Corporation was founded in 1984 and is headquartered in Texas, U.S. The company focuses on manufacturing and sale of pharmaceutical equipment requiring containment technology or a sterile manufacturing environment. It offers business segments including Building Automation (BA), Advanced Automation (AA), and Life Automation (LA) among which Life Automation is the market focused segment. The company’s market focused category is Barrier systems (Isolators).

The company has a wide presence in Europe, Asia-Pacific, Americas, and Middle East & Africa. It has various subsidiaries like Azbil Telstar, S.L.U. (Spain), Azbil North America Research and Development, Inc. (U.S.), Azbil Saudi Limited (Saudi Arabia) among others, among others. As of January 2022, the company has 10,003 employees.